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Summary
Objective—Children with epilepsy (EPI) have a higher rate of ADHD (28–70%) than typically 
developing (TD) children (5–10%); however, attention is multidimensional. Thus, we aimed to 
characterize the profile of attention difficulties in children with epilepsy.
Methods—Seventy-five children with localization-related epilepsy ages 6–16 and 75 age-
matched controls were evaluated using multimodal, multidimensional measures of attention 
including direct performance and parent ratings of attention as well as intelligence testing. We 
assessed group differences across attention measures, determined if parent rating predicted 
performance on attention measures, and examined if epilepsy characteristics were associated with 
attention skills.
Results—The EPI group performed worse than the TD group on timed and complex attention 
aspects of attention (p<.05), while performance on simple visual and simple auditory attention 
tasks was comparable. Children with EPI were 12 times as likely as TD children to have clinically 
elevated symptoms of inattention as rated by parents, but ratings were a weak predictor of 
attention performance. Earlier age of onset was associated with slower motor speed (p<.01), but 
no other epilepsy-related clinical characteristics were associated with attention skills.
Significance—This study clarifies the nature of the attention problems in pediatric epilepsy, 
which may be under recognized. Children with EPI had difficulty with complex attention and 
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rapid response, not simple attention. As such, they may not exhibit difficulty until later in primary 
school when demands increase. Parent report with standard ADHD screening tools may 
underdetect these higher order attention difficulties. Thus, monitoring through direct 
neuropsychological performance is recommended.
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INTRODUCTION
In the general population, Attention Deficit/Hyperactivity Disorder (ADHD) occurs in 
approximately 5–10% of children.1,2,3 In the pediatric epilepsy population, however, the 
prevalence of ADHD is much higher, ranging from 28–70%.4,5,6,7,8 Most studies have 
shown that the Inattentive subtype of ADHD (ADHD-I) is more common in children with 
epilepsy, whereas the Combined subtype of ADHD (ADHD-C) is more common in 
developmental ADHD.6,7,8,9 There are mixed findings about the association between 
attention skills in children with epilepsy and epilepsy-related clinical characteristics such as 
number of anti-epileptic drugs (AEDs), location of seizure focus, epilepsy duration, seizure 
frequency, and age of habitual seizure onset.7,8,10,11,12
The nature of attention difficulties in children with epilepsy has not been fully characterized, 
yet the diagnostic difference of less impulsivity and hyperactivity suggests that children with 
co-morbid epilepsy and ADHD may have a unique cognitive profile. Most previous studies 
are limited by how they assessed attention—either by parent/teacher reports or with a 
continuous performance task.6,7,10,13,14,15,16,17 This study addresses a gap in the literature 
by characterizing attention problems in children with epilepsy with a measure that assesses 
several components of attention. The Test of Everyday Attention for Children (TEA-Ch) 
was developed to measure functionally separable attentional systems in children using visual 
and auditory sensory stimuli in both simple and complex attention tasks (Table 1)18 and has 
been used in several studies of children with ADHD.19,20,21 Two pediatric epilepsy studies 
using the TEA-Ch found that children with epilepsy performed worse than controls; 
however, the sample sizes were small (n=17 and 7) and the authors did not delve into the 
pattern of attention impairments.22,23
The aim of this study is to characterize attentional deficits in a large cohort of children with 
localization related epilepsy (EPI) compared to typically developing (TD) healthy volunteers 
by using a multimodal, multidimensional approach. We hypothesized that children with 
epilepsy will have greater difficulties with attention on direct testing and parent-report 
measures. Specifically, we hypothesized that the EPI group will perform worse than controls 
across attention tasks and demonstrate significant deficits for tasks with auditory and 
speeded demands.9,10,12,17 We also hypothesized that parent report of inattentive symptoms 
will be higher in children with EPI than TD children and predict performance on direct 
measures of attention. We expected that more AEDs, frontal foci, longer epilepsy duration, 
greater seizure frequency, and younger age of onset will be associated with worse 
performance and higher parent ratings of inattention.
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One hundred and fifty children ages 6–15 were included in the study if they had completed 
the TEA-Ch and intellectual testing (Table 2). Seventy-five children with a confirmed 
diagnosis of localization-related epilepsy were age-matched to 75 typically developing 
children. Participants were recruited through multiple clinical research protocols with 
primary aims different from this study but included common measures. Children were 
excluded if IQ<70 to rule out global impairment as the reason for attention problems.
Characteristics of children with epilepsy are detailed in Table 3. Seizure type was 
determined by a neurologist who made the diagnosis of focal epilepsy with alteration of 
consciousness from clinical features, neurologic examination, (video-) EEG, and/or high 
resolution epilepsy protocol MRI. Children with primary generalized epilepsy were 
excluded; however, seven (9.3%) have secondarily generalized seizures. Most children with 
epilepsy had left-hemisphere localized seizures due to a recruiting bias of the primary aims 
of several of our clinical research protocols that examine language reorganization and have 
left-sided seizure focus as an inclusion criterion.24,25,26,27 Most children with epilepsy had 
normal MRI findings as children. Children were excluded if large (i.e., multi-lobar) 
abnormalities, tumors, or vascular etiologies including stroke were evident on MRI. 
However, 19 children (25.3%) with smaller lesions including mesial temporal sclerosis, 
small focal cortical dysplasias, or nonspecific increased signal changes were included in the 
study. Number of anti-epileptic drugs ranged from none to four; specific drugs are included 
in supporting information. Mean age of habitual seizure onset was 6.27 years old (SD=3.17). 
Seven children with epilepsy had been previously diagnosed with ADHD, three of whom 
were taking stimulant medication at the time of testing. In the EPI group, one child had a 
history of anxiety and one had a history of depression. TD children were excluded if there 
was a known history of a medical disorder or CNS injury (i.e., diabetes, infection, head 
injury, etc.), learning disabilities, ADHD, or a significant ongoing medical condition.
The study was approved by Children’s National Medical Center Institutional Review Board, 
with informed consent provided by the parents, and assent provided by all children.
Measures
Direct Measure of Attention—The TEA-Ch28 is a standardized clinical battery designed 
to assess attention across various component skills in children. All nine subtests of the TEA-
Ch could not be administered due to practical time constraints given that children were 
participating as part of a larger clinical research protocol that assessed several cognitive 
domains. We used four subtests to assess simple visual attention (Sky Search), simple 
auditory attention (Score), complex auditory attention (Score Dual Task (Score DT)), and 
multimodal (auditory and visual) complex attention (Sky Search Dual Task (Sky Search 
DT)). We selected these four subtests of the TEA-Ch to be able to look first at a basic level 
skill, then examine the complex versions where the same basic skills are then combined. We 
also wanted to include some tasks that had no graphomotor demands given that motor skills 
can be affected by medications. We included the scaled scores for the accuracy and timed 
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components from the Sky Search subtest. A single scaled score is generated from the other 
three subtests. Detailed descriptions of subtests are provided in Table 1 and Supporting 
Information.
Parent Rating of Attention—The ADHD Rating Scale-IV29 is a standardized parent 
questionnaire that corresponds to the 18 symptoms for ADHD from the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV), including nine symptoms 
of inattention and nine symptoms of hyperactivity/impulsivity. Parents rate symptom 
frequency over the past 6 months on a four point Likert scale ranging from “Never” to 
“Very Often.” Normative T-scores from the Inattention and Hyperactive/Impulsive 
subscales are generated. In addition, symptoms rated as “Often” or “Very Often” are 
considered clinically significant. T-scores and the raw number of clinically significant 
symptoms (e.g., rated 2 or 3) for Inattention and Hyperactivity/Impulsivity subscales were 
used in statistical analyses.
Intelligence Testing—The Wechsler Abbreviated Scale of Intelligence (WASI)30 is a 
brief assessment battery of intelligence for ages 6–89. It consists of four subtests: two 
assessing verbal skills and two assessing nonverbal reasoning abilities. These four subtests 
yield a verbal intelligence quotient (VIQ), a performance intelligence quotient (PIQ), and a 
full-scale intelligence quotient (FSIQ). We examined VIQ and PIQ independently in our 
analyses given that one PIQ subtest is timed and may be influenced by motor speed, which 
we hypothesized may be lower in children with epilepsy.
Data Analysis
Statistical analyses were conducted using SPSS version 21.0 using the appropriate 
parametric or nonparametric analysis corrected for multiple comparisons. Sample 
characteristics (e.g., age, gender) and their potential effect on the primary hypotheses of 
interest were assessed with descriptive and correlational analyses. The primary analyses 
(multivariate analyses of variance; MANOVA) assessed group (EPI/TD) differences on 1) 
direct measures and 2) parent ratings of attention. Post-hoc analysis determined specifically 
which subtests were different. Linear regression was conducted to determine if parent-rating 
scores predicted performance on direct measures of attention. Additional analyses focused 
on the impact of epilepsy characteristics on direct and parent reported attention. 
Characteristics of interest included: a) number of antiepileptic medications (≤ 1 and ≥ 2), b) 
seizure focus (frontal, temporal, frontotemporal), c) duration of epilepsy (new onset (< 3 
years) and chronic (>3 years)), d) seizure frequency in previous 6 months (none, weekly, 
monthly), and e) age of habitual onset. Categorical distinctions for some linear variables 
were selected based on a restricted or skewed range of values, clinical relevance, and/or to 
distribute cell counts to optimize statistical analyses (Table 3). To reduce multiple 
comparisons, epilepsy characteristics and linear regression of parent-report were only 
conducted for the attention variables that were found to differ between the EPI and TD 
group. That number of variables was then used to set a Bonferroni corrected threshold (.05/5 
= p<.01).
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EPI and TD groups were similar in terms of age and gender, thus these factors were not 
included in further analyses. Although IQ for both groups fell in the Average range, the TD 
group had significantly higher VIQ and PIQ than the EPI group (Table 2). VIQ was included 
as a covariate in the MANOVA to account for group differences in IQ while preserving 
differences related to motor speed that also shares variance with PIQ.
Attention
Direct Measure—Overall, the EPI group performed worse than the TD group on the TEA-
Ch subtests (F5,143= 3.56, p = .005; Figure 1 and Table 4). Post-hoc analysis demonstrated 
that the EPI group was slower than the TD group at target identification during the simple 
visual task (F1,147= 5.82, p = .017, d = .51). The EPI group also performed worse on both 
subtests of complex attention: Sky Search DT (F1,147= 11.09, p = .001, d = .64) and Score 
DT (F1,147= 6.15, p = .016, d = .56). A majority (64% Score DT and 68% Sky Search DT) 
of the EPI group performed at least a standard deviation below the normative average. In 
contrast, the EPI group demonstrated similar accuracy to the TD group on the simple 
attention tasks (Sky Search: p = .36; Score p = .20), with both groups performing in the 
average range.
Parent Rating—Parents of the EPI group were 12 ½ times more likely than parents of the 
TD group to report clinically elevated levels (≥ 6 symptoms) of inattention (χ2 = 11.81, p = .
001, OR = 12.66); no group difference was found for symptoms of hyperactivity (χ2 = 1.03, 
p = .310). Twenty-four percent of the EPI group met DSM-IV symptom criteria for an 
ADHD diagnosis based on parent ratings (Table 5), compared to 4% of controls. Linear 
regressions revealed that parent ratings of inattention predicted two aspects of attention 
performance: speed and complex auditory attention, accounting for 7% and 10% of the 
variance respectively (Sky Search Time per Target: F (1,136) = 10.19, p = 0.002; Score! 
DT: F (1,136) = 14.86, p < 0.001). There was a trend for parent ratings to predict complex 
visual and auditory attention, predicting 3% of the variance (Sky Search DT: F (1,136) = 
3.40, p = 0.07).
Epilepsy-related Clinical Characteristics—Earlier age of onset was associated with 
slower motor speed (r = .32, p = .005). In addition, parents of children experiencing weekly 
seizures reported more symptoms of hyperactivity than parents of children with no seizures 
in the previous 6 months (U = 82.50, p = .005, d = .69). Although not significant with the 
Bonferroni-corrected threshold, there was a large effect size31 for number of clinical 
symptoms of attention for parents of children with chronic epilepsy compared to recent-
onset epilepsy (t66 = −2.27, p = .03, d = .56). Neither number of AEDs nor the location of 
the epileptogenic foci was related to direct or parent measures of attention (p’s>.60).
Berl et al. Page 5














We found that children with localization-related epilepsy performed worse than TD children 
on complex and timed attention tasks, with a majority of the EPI group performing below 
average on the complex attention tasks. Moreover, this was not due to IQ differences, which 
were accounted for statistically. Notably, the EPI group performed comparably to the TD 
group on simple visual and auditory tasks. Parents of children with EPI endorsed more 
DSM-IV symptoms of ADHD than parents of the TD group, with 24% of the EPI group 
meeting criteria for an attention disorder. Parent ratings weakly predicted direct performance 
on attention measures, indicating the need for both methods of assessment. Attention 
difficulties were not related to specific epilepsy-related clinical characteristics but slow 
motor speed was related to earlier age of onset and increased hyperactivity was associated 
with more frequent seizures. Our elucidation of the nature of attention problems in children 
with localization-related epilepsy has important implications for understanding the clinical 
course of the cognitive comorbidities of epilepsy. Identifying the specific attentional 
weaknesses common to children with epilepsy will inform diagnostic and treatment 
decisions. This information is particularly important given the association between ADHD 
and reduced school performance and academic attainment.32
Diagnostic Implications
A child with epilepsy who has the attention profile found in our study may not necessarily 
exhibit functional impairments until complexity or demands for speed increase. Typically 
these increased demands are required later in a child’s education when he or she is asked to 
attend to two tasks simultaneously (e.g., listening to the teacher while taking notes). 
Therefore, a child with epilepsy may not present to a medical provider until later in 
childhood because their age-appropriate simple attentional skills buoy them during the early 
years. This clinical presentation may lead to diagnostic uncertainty or even under diagnosis. 
One issue is that the DSM inattentive symptoms reflect simple inattention (e.g., failure to 
give close attention to details, not listening when spoken to directly, difficulty with sustained 
attention) rather than complex demands for dividing or shifting attention. Another issue is 
the required presence of several symptoms prior to age 7 in order to meet the DSM-IV 
criteria. These issues potentially explain the large range of ADHD comorbidity rates in 
epilepsy (28–70%) in the existing literature.4,5,6,7,8 Recent DSM-5 changes that increase the 
onset age from 7 to 12 may help to clarify rates of ADHD comorbidity in children with 
epilepsy.
The children with epilepsy in our study have generally well-controlled localization related 
epilepsy, average IQ, and average simple attention. They are at risk because problems with 
complex attention may be missed and thus go undiagnosed and untreated. This is reflected in 
our findings as 17 children with epilepsy met ADHD criteria via parent-reported symptoms, 
but only 4 had been previously diagnosed with ADHD. Our sample is similar to previous 
studies in that the inattentive subtype of ADHD was the most common presentation. 
Moreover, the frequency of ADHD—based on parent report—in our pediatric epilepsy 
sample (24%) is similar to the frequency of ADHD in epilepsy seen in a large (n=284,419) 
pediatric epidemiological study (28%).4 The rate of impairment was strikingly higher (64–
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68%) on direct measures of complex attention; however, indicating that clinicians should 
recommend neuropsychological evaluation in pediatric epilepsy even if parent reported 
symptoms are low, and other information indicates declining performance (e.g., grades, test 
performance).
Treatment Implications
Medications have been shown to improve symptoms of ADHD including stimulant 
(methylphenidate (MPH) and amphetamine) and non-stimulant medications (atomoxetine, 
guanfacine, and clonidine). While some concerns remain, the majority of recent studies have 
demonstrated that MPH does not increase seizure frequency or change EEG patterns in 
children with well-controlled epilepsy.33,34,35,36,37 Furthermore, MPH reduces symptoms of 
inattention and hyperactivity34,35,37 and leads to improved performance on a computerized 
CPT in children with epilepsy.36 In developmental ADHD, MPH has demonstrated 
significant improvement effects on motor and speeded task performance, which could be 
helpful for children with comorbid epilepsy and ADHD. The positive impact of stimulants is 
more equivocal with respect to other higher order cognitive skills such as complex attention, 
working memory, or academic achievement. While there is evidence that stimulants improve 
academics38,39 and complex attention/working memory40 others suggest that the effects are 
modest on academics41 or that there is not improvement in complex attention (dual-task) 
performance in children with ADHD.20,42 Thus, having a child’s profile of attentional 
difficulties may be informative in understanding and predicting response/nonresponse to 
stimulants.
Implications Related to Epilepsy
Epilepsy is a heterogeneous medical condition but a majority of individuals have average 
IQ.43 We were able to control for some factors by excluding patients with generalized 
epilepsy, large structural abnormalities, or IQ<70. Within our group, problems with complex 
attention problems were pervasive regardless of age of habitual seizure onset, seizure 
frequency, number of medications, or seizure location. However, the children with early age 
of habitual seizure onset demonstrated slower motor speed. Perhaps the motor system is 
vulnerable to early neurological disruption related to seizures or treatments. We also found 
that EPI children with hyperactive symptoms had greater seizure frequency (weekly), which 
suggests that greater disease burden is associated with a more severe ADHD presentation.
Our results expand the interpretation of previous studies in pediatric epilepsy that have 
largely used a computerized continuous performance task (CPT) to assess attention. The 
CPT requires children to quickly press a button for visual targets while ignoring non-target 
items. On this type of task children with epilepsy have difficulty with sustained attention due 
to omission errors.10,15,17 In light of our results, we propose that the quick motor response 
required for the CPT may be the specific liability rather than the demand for sustained 
simple attention. The CPT is often used, particularly in drug studies, due to its ease of 
administration44; however, it may not adequately assess attentional impairments in children 
with epilepsy. Our findings suggest that using measures that distinguish among several 
components of attention (e.g., different modalities and levels of complexity) is important to 
accurately identify the core difficulties of children with localization-related epilepsy.
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Future studies could further investigate clinical characteristics of epilepsy not evaluated here 
such as other epilepsy types (e.g., generalized epilepsy, epilepsy syndromes), specific AED 
effects, or specific MRI findings. A second limitation is that we did not have an ADHD-only 
group to better isolate the unique effects of seizures on attentional functioning. Another 
potential limitation is that three children in our EPI sample were taking a stimulant at the 
time of testing; however as noted above, a prior study indicated that MPH would not have 
affected TEA-Ch performance on the dual tasks but could have bolstered motor task 
performance. Nonetheless, if MPH had neuroenhancing effects that produced better 
performance across TEA-Ch tasks for these participants, it would only have made it more 
difficult for our group differences to reach statistical significance.
Conclusions
Children with localization-related epilepsy and average IQ demonstrate difficulty with 
attention as complexity and time demands increase, while they maintain their ability to 
attend to simple visual and auditory stimuli. Poor attention was not associated with seizure 
frequency, number of antiepileptic medications, age of onset, or location of seizure focus. 
This translates to diagnostic and treatment implications for pediatricians who may assume 
the majority of their medical care. Diagnostically, 24% of children with epilepsy meet 
criteria for an attention disorder based on parent ratings, but a higher prevalence of 
difficulties (64–68%) is evident on direct testing that distinguishes between timed/untimed 
and simple/complex attention demands. Treatment decisions and response are better 
informed with this more comprehensive view of the attention difficulties in pediatric 
epilepsy. Future studies that assess attention profiles in order to predict response to stimulant 
treatment and specify the developmental timing of these attention problems will be 
informative.
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Performance differences across subtests from the Test of Everyday Attention for Children 
(TEA-Ch). Dotted line indicates performance 1 SD below average. *= p< .01.
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Table 1
Description of Test of Everyday Attention for Children (TEA-Ch) subtests
Subtest Level Modality Attentional Skill(s) Skill Definition
Sky Search Simple Visual Selective Attention The capacity to select target information from an array of 
distractors.
Score! Simple Auditory Sustained Attention The capacity to maintain focus and alertness over time.
Sky Search DT Complex Visual & Auditory Divided Attention
 Selective Attention
 Sustained Attention
(Div. Attn) The capacity to change attentive focus in a flexible 
and adaptive manner; the ability to attend to more than one 
stimulus at the same time.
Score! DT Complex Auditory Divided Attention
 Selective Attention
 Sustained Attention
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Table 3
Epilepsy characteristics of patient population.
Count (Percentage) (n=75)
Chronicity
Diagnosis 0–3 yrs ago 32 (43%)
Diagnosis >3 yrs ago 43 (57%)
Hemisphere of Seizure Focus
Left Hemisphere 54 (72%)
Right Hemisphere 17 (22%)
Bilateral 3 (4%)
Undetermined 1 (1%)





 Undetermined 21 (28%)
 Parietal 2 (3%)
 Occipital 2 (3%)
 Frontal-Parietal 1 (1%)
 Temporal-Parietal 3 (4%)
 Temporal-Occipital 1(1%)
Number of Current AEDs
0 or 1 44 (58%)
 0 6 (8%)
 1 38 (50%)
2 or more 31 (41%)
 2 19 (25%)
 3 6 (8%)
 4 6 (8%)






Data are presented as frequency (percentage) unless otherwise noted.
*
Occasional denotes 1–5 seizures in the previous 6 months.
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Table 4
EPI (n=75) and TD (n=75) performances on subtests of attention.
Group M (SD) CI 95% p value
Sky Search: Accuracy
EPI 10.04 (3.65) 9.30 – 10.78 .362
TD 10.55 (2.76) 9.81 – 11.29
Sky Search: Time per Target EPI 7.85 (3.14) 7.21 – 8.48 .017
TD 8.96 (2.33) 8.32 – 9.59
Score! EPI 7.61 (3.77) 6.77 – 8.45 .200
TD 8.42 (3.54) 7.58 – 9.26
Sky Search DT EPI 5.65 (3.97) 4.79 – 6.50 .001
TD 7.72 (3.43) 6.87 – 8.58
Score! DT EPI 7.79 (3.46) 7.03 – 8.56 .016
TD 9.18 (3.40) 8.41 – 9.94
Data are presented as mean (M), standard deviation (SD), and 95% confidence interval (CI).
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Table 5
Parent reported ADHD symptoms.
Patients (n=68) Controls (n=75)
>5 ADHD-I symptoms 19% 1%
>5 ADHD-HI symptoms 1% 0%
>5 ADHD-I symptoms and >5 ADHD-HI symptoms 4% 3%
TOTAL 24% 4%
ADHD percentages represent the frequency of those who meet DSM-IV criteria for ADHD (6+ symptoms) based on parent rating of inattentive 
(ADHD-I) and hyperactive-impulsive (HI) symptoms on the DuPaul rating scale.
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